Evidence map›Paper›PMID 31127770›Full record

ReviewJournal of Alzheimer's disease : JAD2019

A Bird's-Eye View of the Multiple Biochemical Mechanisms that Propel Pathology of Alzheimer's Disease: Recent Advances and Mechanistic Perspectives on How to Halt the Disease Progression Targeting Multiple Pathways.

Caleb Vegh, Kyle Stokes, Dennis Ma, Darcy Wear, Jerome Cohen, Sidhartha D Ray, Siyaram Pandey

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of Alzheimer's disease : JAD, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in aging neuroscience · 2023
    Article
  4. Vanillic acid attenuates HFrontiers in pharmacology · 2022
    Article
  5. Article
  6. Article
  7. Combined Ubisol-QAntioxidants (Basel, Switzerland) · 2021
    Article
  8. Review
  9. Diesel Exhaust Extract Exposure Induces Neuronal Toxicity by Disrupting Autophagy.Toxicological sciences : an official journal of the Society of Toxicology · 2020
    Article
  10. Resumption of Autophagy by Ubisol-QOxidative medicine and cellular longevity · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Caleb VeghDepartment of Chemistry and Biochemistry University of Windsor, Ontario, Canada.
Kyle StokesDepartment of Chemistry and Biochemistry University of Windsor, Ontario, Canada.
Dennis MaDepartment of Chemistry and Biochemistry University of Windsor, Ontario, Canada.
Darcy WearDepartment of Chemistry and Biochemistry University of Windsor, Ontario, Canada.
Jerome CohenDepartment of Psychology University of Windsor, Ontario, Canada.
Sidhartha D RayDepartment of Pharmaceutical and Biomedical Sciences, Touro College of Pharmacy and School of Medicine, Manhattan, NY, USA.
Siyaram PandeyDepartment of Chemistry and Biochemistry University of Windsor, Ontario, Canada.
University of Windsor · CATouro College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurons consume the highest amount of oxygen, depend on oxidative metabolism for energy, and survive for the lifetime of an individual. Therefore, neurons are vulnerable to death caused by oxidative-stress, accumulation of damaged and dysfunctional proteins and organelles. There is an exponential increase in the number of patients diagnosed with neurodegenerative diseases such as Alzheimer's (AD) as the number of elderly increases exponentially. Development of AD pathology is a complex phenomenon characterized by neuronal death, accumulation of extracellular amyloid-β plaques and neurofibrillary tangles, and most importantly loss of memory and cognition. These pathologies are most likely caused by mechanisms including oxidative stress, mitochondrial dysfunction/stress, accumulation of misfolded proteins, and defective organelles due to impaired proteasome and autophagy mechanisms. Currently, there are no effective treatments to halt the progression of this disease. In order to treat this complex disease with multiple biochemical pathways involved, a complex treatment regimen targeting different mechanisms should be investigated. Furthermore, as AD is a progressive disease-causing morbidity over many years, any chemo-modulator for treatment must be used over long period of time. Therefore, treatments must be safe and non-interfering with other processes. Ideally, a treatment like medicinal food or a supplement that can be taken regularly without any side effect capable of reducing oxidative stress, stabilizing mitochondria, activating autophagy or proteasome, and increasing energy levels of neurons would be the best solution. This review summarizes progress in research on different mechanisms of AD development and some of the potential therapeutic development strategies targeting the aforementioned pathologies.

Indexed as

Alzheimer DiseaseAnimalsAutophagyDisease ProgressionHumansOxidative StressSignal TransductionAlzheimer’s diseaseamyloid-β plaquesashwagandhaautophagymitochondrial dysfunctionoxidative stresspresenilin-1water-soluble coenzyme-Q10

Identifiers

PMID31127770
PMCPMC6598003
OpenAlexW2946684713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.